Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Category
Equity - Leveraged / Inverse
Sponsor
Defiance ETFs
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
1.32%
Inverse/Leveraged
IPO
Aug 08, 2024
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-4.31%
SMA50
-0.25%
SMA200
14.74%
Return% 1Y
73.39%
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
-33.61%
Flows% 3M
-49.27%
Flows% YTD
16.89%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
9
AUM
45.81M
NAV/sh
52W High
29.95 -14.79%
52W Low
9.60 165.84%
Volatility
4.67% 5.66%
ATR (14)
1.57
RSI (14)
47.05
Beta
0.60
Rel Volume
0.75
Avg Volume
478.70K
Volume
17,964
Perf Week
-6.34%
Perf Month
-9.53%
Perf Quarter
38.33%
Perf Half Y
9.49%
Perf YTD
0.12%
Perf Year
72.79%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
24.96
Price
25.52
Change
2.25%
Apr-22-25 08:07AM
Defiance Daily Target 2X Long LLY ETF seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company. The fund will enter into one or more swap agreements with financial institutions for a specified period, which may range from one day to longer than a year. The advisor has adopted a policy to have at least 80% exposure to financial instruments with economic characteristics that should perform 2X the daily performance of the underlying security's shares. The fund is non-diversified.